GMAB earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E 21.61. Updated 2026-07-23.
Genmab (GMAB) Research Hub
Genmab (GMAB) trades on NASDAQ, DK in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 44.69 USD (+2.06%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 21.61, market cap 17.82B. This hub links to the full technical, earnings and options research available for GMAB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, DK |
| Last close | 44.69 USD (+2.06%) |
| 52-week range | 24.51 USD – 45.45 USD |
| Trend regime | Range |
| 14-day RSI | 75.3 (Overbought) |
| Trailing P/E | 21.61 |
| Market cap | 17.82B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for GMAB
Covered Call on GMAB: how it works, illustrative setup around the real 44.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GMAB: how it works, illustrative setup around the real 44.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GMAB: how it works, illustrative setup around the real 44.69 USD price, max profit/loss, breakeven and when to use it. Educational.
GMAB technical analysis: range, last 44.69 USD, RSI 75.3, 52w range 24.51 USD–45.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GMAB in?
Genmab (GMAB) is classified under Healthcare (Biotechnology), listed on NASDAQ, DK.
Is GMAB in an uptrend or downtrend?
As of 2026-10-26, GMAB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GMAB's trailing P/E ratio?
GMAB's trailing P/E is 21.61, with a market cap of 17.82B. See the earnings research page for full valuation detail.
When does GMAB next report earnings?
GMAB is next scheduled to report earnings on 2026-08-06.